High Tide Celebrates Fifth Consecutive Year on Canada’s Top Growing Companies List

An announcement from High Tide ( (TSE:HITI) ) is now available.

High Tide Inc. has been recognized for the fifth consecutive year as one of Canada’s Top Growing Companies by the Report on Business, ranking 182nd with a three-year revenue growth rate of 188%. This achievement underscores the company’s successful retail model and loyal customer base. Additionally, High Tide’s recent acquisition of Remexian marks its entry into Europe’s largest cannabis market, which is expected to enhance its revenue profile and international presence, offering new opportunities for long-term growth.

The most recent analyst rating on (TSE:HITI) stock is a Buy with a C$7.25 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.

Spark’s Take on TSE:HITI Stock

According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.

High Tide’s overall stock score is driven by strong financial performance and positive earnings call sentiment, highlighting growth in retail expansion and market share. However, the technical indicators suggest the stock may be overbought, and the negative P/E ratio reflects ongoing profitability challenges.

To see Spark’s full report on TSE:HITI stock, click here.

More about High Tide

High Tide, Inc. is a leading cannabis enterprise with a focus on retail and medical cannabis distribution. Its subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally, with a significant presence in Canada. The company also operates e-commerce platforms for accessories and hemp-derived CBD products and has expanded into the European market through its acquisition of Remexian Pharma GmbH, a German pharmaceutical company specializing in medical cannabis distribution.

Average Trading Volume: 109,017

Technical Sentiment Signal: Buy

Current Market Cap: C$470.4M

For detailed information about HITI stock, go to TipRanks’ Stock Analysis page.